| 摘要 |
<p>The use of 2-iminobenzothiazolines of formula (II), wherein R is a polyfluoroalkoxy or polyfluoroalkyl radical, R1 is a hydrogen atom or a C1-4 alkyl radical, R2 is a 2-propynyl, -alk-S(O)n-alk, -alk-SO2-NH2, -alk-SO2-NHalk or 4-phenylpiperazinylethyl radical, n is 0, 1 or 2 and alk is alkyl, and enantiomers, diastereoisomers and pharmaceutically acceptable salts thereof, for treating Parkinson's disease and parkinsonian syndromes, is disclosed.</p> |
